Björn Bauer1, David S Miller, Gert Fricker. 1. Institute of Pharmacy and Molecular Biotechnology, University of Heidelberg, INF 366 69120 Heidelberg, Germany.
Abstract
PURPOSE: The purpose of this study was to establish a fluorescent dye (calcein-acetoxymethylester; calcein-AM)-based assay to rapidly screen compounds for interactions with p-glycoprotein (p-gp) at the blood-brain barrier and to determine whether such an assay can be useful for kinetic analysis. METHODS: Porcine brain capillary endothelial cells (PBCECs) were isolated and cultured in 96-well plates. Cells were incubated with calcein-AM in the absence and presence of substrates and inhibitors of ABC transporters and the extent of intracellularly appearing fluorescence was monitored with a fluorescence plate reader in a time-and a concentration-dependent manner. RESULTS: PBCECs showed stable expression of p-gp and as a result calcein-AM was extruded by the cells. In the presence of p-gp substrates and inhibitors a significant increase of intracellular fluorescence was observed (decreased calcein-AM efflux), the increase being well correlated with the p-gp affinity of the compounds used. Inhibitors of Mrpl and Mrp2 did not influence fluorescence intensity. Time-dependent readouts and Michaelis-Menten kinetic analysis separated inhibitors into those showing competitive, mixed and non-competitive inhibition of p-glycoprotein-mediated transport. CONCLUSION: The calcein-AM-assay based on PBCECs can be used as a rapid microplate screening system for interactions of drugs with p-glycoprotein at the blood-brain barrier and represents therefore a useful tool in the profiling of drugs. In addition, convenient kinetic assays can provide information about the mode of interaction.
PURPOSE: The purpose of this study was to establish a fluorescent dye (calcein-acetoxymethylester; calcein-AM)-based assay to rapidly screen compounds for interactions with p-glycoprotein (p-gp) at the blood-brain barrier and to determine whether such an assay can be useful for kinetic analysis. METHODS: Porcine brain capillary endothelial cells (PBCECs) were isolated and cultured in 96-well plates. Cells were incubated with calcein-AM in the absence and presence of substrates and inhibitors of ABC transporters and the extent of intracellularly appearing fluorescence was monitored with a fluorescence plate reader in a time-and a concentration-dependent manner. RESULTS: PBCECs showed stable expression of p-gp and as a result calcein-AM was extruded by the cells. In the presence of p-gp substrates and inhibitors a significant increase of intracellular fluorescence was observed (decreased calcein-AM efflux), the increase being well correlated with the p-gp affinity of the compounds used. Inhibitors of Mrpl and Mrp2 did not influence fluorescence intensity. Time-dependent readouts and Michaelis-Menten kinetic analysis separated inhibitors into those showing competitive, mixed and non-competitive inhibition of p-glycoprotein-mediated transport. CONCLUSION: The calcein-AM-assay based on PBCECs can be used as a rapid microplate screening system for interactions of drugs with p-glycoprotein at the blood-brain barrier and represents therefore a useful tool in the profiling of drugs. In addition, convenient kinetic assays can provide information about the mode of interaction.
Authors: A M Taylor; J Storm; L Soceneantu; K J Linton; M Gabriel; C Martin; J Woodhouse; E Blott; C F Higgins; R Callaghan Journal: Br J Pharmacol Date: 2001-12 Impact factor: 8.739
Authors: Andreas Noack; Sandra Noack; Andrea Hoffmann; Katia Maalouf; Manuela Buettner; Pierre-Olivier Couraud; Ignacio A Romero; Babette Weksler; Dana Alms; Kerstin Römermann; Hassan Y Naim; Wolfgang Löscher Journal: PLoS One Date: 2014-02-04 Impact factor: 3.240
Authors: Dominik Wupperfeld; Gert Fricker; Béatrice Bois De Fer; Larissa Frank; Annika Wehrle; Branko Popovic Journal: Lipids Health Dis Date: 2022-09-24 Impact factor: 4.315